✦ LIBER ✦

Highlight: BRCA1 and BRCA2 proteins in breast cancer

✍ Scribed by Dianne C. Daniel

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 431 KB
Volume: 59
Category: Article
ISSN: 1059-910X
DOI: 10.1002/jemt.10178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 and BRCA2 in Indian breast cancer

BRCA1 and BRCA2 in Indian breast cancer patients

✍ Sunita Saxena; Csilla I. Szabo; Sandrine Chopin; Laure Barjhoux; Olga Sinilnikov 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

Incidence of breast cancer in Indian women is not as high as in Western countries, nonetheless age-adjusted incidence rates (AAR) have risen from 17.9 to 24.9 per 100,000 from 1965 to 1985. Although these rates are still approximately one quarter to one third of incidence rates in North America and

BRCA1 and BRCA2 mutations in Russian fam

BRCA1 and BRCA2 mutations in Russian familial breast cancer

✍ Irina V. Tereschenko; Victoria M. Basham; Bruce A.J. Ponder; Paul D.P. Pharoah 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie

BRCA1 and BRCA2 sequence variants in Chi

BRCA1 and BRCA2 sequence variants in Chinese breast cancer families

✍ Xiangcheng Zhi; Csilla Szabo; Sandrine Chopin; Nicola Suter; Qing-Sheng Wang; El 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

A series of 45 high-risk breast cancer patients, consisting of 25 affected individuals from 16 families in China with at least two cases of breast cancer and 20 cases of breast cancer diagnosed under age 35 without reported family history, were studied for germline mutations of the BRCA1 and BRCA2 g

Clinical management of BRCA1- and BRCA2-

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

Cancer predisposing missense and protein

Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families

✍ Sylvia De Brakeleer; Jacques De Grève; Remy Loris; Nicolas Janin; Willy Lissens; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Fifteen years ago BRCA1 and BRCA2 were reported as high penetrant breast cancer predisposing genes. However, mutations in these genes are found in only a fraction of high risk families. BARD1 is a candidate breast cancer gene, but only a limited number of missense mutations with rather unclear patho

BRCA1 gene in breast cancer

✍ Eliot M. Rosen; Saijun Fan; Richard G. Pestell; Itzhak D. Goldberg 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

## Abstract The __BRCA1__ gene was identified and cloned in 1994 based its linkage to early onset breast cancer and breast‐ovarian cancer syndromes in women. While inherited mutations of BRCA1 are responsible for about 40–45% of hereditary breast cancers, these mutations account for only 2‐3% of al